SUTRO BIOPHARMA INC shareholders Q3 2023

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

SUTRO BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
VANGUARD GROUP INC 2,868,762$9,954,6040.00%
Bank of New York Mellon Corp 261,451$907,2350.00%
PUTNAM INVESTMENTS LLC 68,393$237,3240.00%
Citadel Advisors 1,000$3,4700.00%
Citadel Advisors 1,100$3,8170.00%
Citadel Advisors 48,589$168,6040.00%
ROYAL BANK OF CANADA 10,119$35,0000.00%
BARCLAYS PLC 62,579$2170.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 120,405$417,8050.00%
AQR Capital Management 23,758$82,4400.00%
Nuveen Asset Management, LLC 212,145$736,1430.00%
Daiwa Securities Group Inc. 158$10.00%
JPMORGAN CHASE & CO 76,824$266,5790.00%
Bogart Wealth, LLC 500$1,7350.00%
Qube Research & Technologies Ltd 4,953$17,1870.00%
Washington Trust Advisors, Inc. 179$6220.00%
AMALGAMATED BANK 5,698$200.00%
PRINCIPAL FINANCIAL GROUP INC 22,150$76,8600.00%
OSAIC HOLDINGS, INC. 10,250$35,5680.00%
FMR LLC 80,260$278,5020.00%
External links

This page lists SUTRO BIOPHARMA INC's shareholders in Q3 2023. To view SUTRO BIOPHARMA INC's shareholder history, click here.